Heron Therapeuti Stock Five Year Return

HRTX Stock

USD 1.14 0.07 6.54%

Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Heron Therapeuti Company Five Year Return Analysis

Heron Therapeuti's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

Five Year Return

(Mean of Monthly Returns - 1)

X

100%

More About Five Year Return | All Equity Analysis

Heron Five Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Five Year Return. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.78	0.07	-0.65	0.78	0.5	1.0	0.41	0.35	-0.06	0.88	0.6	0.7	0.82	0.76	0.31	0.83	0.85	0.85	0.27
Total Stockholder Equity	0.78		-0.51	-0.04	0.29	-0.15	0.83	0.28	0.34	-0.19	0.87	-0.01	0.22	0.99	0.2	0.09	0.4	0.9	0.9	-0.31
Net Debt	0.07	-0.51		-0.7	0.51	0.81	0.0	-0.26	-0.2	0.27	-0.05	0.75	0.49	-0.44	0.61	-0.07	0.34	-0.16	-0.16	0.83
Retained Earnings	-0.65	-0.04	-0.7		-0.88	-0.97	-0.58	-0.29	-0.06	-0.15	-0.34	-0.98	-0.83	-0.12	-0.98	-0.34	-0.85	-0.24	-0.24	-0.84
Net Receivables	0.78	0.29	0.51	-0.88		0.83	0.75	0.44	0.39	0.13	0.55	0.83	0.89	0.38	0.92	0.49	0.91	0.45	0.46	0.66
Total Liab	0.5	-0.15	0.81	-0.97	0.83		0.43	0.25	0.08	0.17	0.2	0.96	0.8	-0.07	0.93	0.37	0.76	0.1	0.1	0.86
Total Current Assets	1.0	0.83	0.0	-0.58	0.75	0.43		0.42	0.4	-0.08	0.91	0.53	0.66	0.87	0.7	0.32	0.8	0.88	0.88	0.2
Short Term Debt	0.41	0.28	-0.26	-0.29	0.44	0.25	0.42		0.62	-0.14	0.13	0.15	0.48	0.29	0.32	0.95	0.58	0.1	0.1	0.04
Accounts Payable	0.35	0.34	-0.2	-0.06	0.39	0.08	0.4	0.62		-0.2	0.33	-0.08	0.3	0.34	0.1	0.66	0.36	0.26	0.27	-0.2
Common Stock	-0.06	-0.19	0.27	-0.15	0.13	0.17	-0.08	-0.14	-0.2		-0.11	0.19	0.22	-0.16	0.12	-0.06	0.07	-0.08	-0.07	0.27
Short Term Investments	0.88	0.87	-0.05	-0.34	0.55	0.2	0.91	0.13	0.33	-0.11		0.3	0.46	0.9	0.48	0.02	0.56	0.96	0.97	0.03
Property Plant Equipment	0.6	-0.01	0.75	-0.98	0.83	0.96	0.53	0.15	-0.08	0.19	0.3		0.79	0.07	0.96	0.22	0.78	0.24	0.24	0.85
Current Deferred Revenue	0.7	0.22	0.49	-0.83	0.89	0.8	0.66	0.48	0.3	0.22	0.46	0.79		0.29	0.86	0.52	0.87	0.41	0.41	0.61
Net Tangible Assets	0.82	0.99	-0.44	-0.12	0.38	-0.07	0.87	0.29	0.34	-0.16	0.9	0.07	0.29		0.28	0.11	0.46	0.92	0.92	-0.22
Capital Surpluse	0.76	0.2	0.61	-0.98	0.92	0.93	0.7	0.32	0.1	0.12	0.48	0.96	0.86	0.28		0.35	0.88	0.4	0.4	0.77
Short Long Term Debt	0.31	0.09	-0.07	-0.34	0.49	0.37	0.32	0.95	0.66	-0.06	0.02	0.22	0.52	0.11	0.35		0.57	-0.02	-0.02	0.16
Long Term Debt Total	0.83	0.4	0.34	-0.85	0.91	0.76	0.8	0.58	0.36	0.07	0.56	0.78	0.87	0.46	0.88	0.57		0.47	0.47	0.62
Net Invested Capital	0.85	0.9	-0.16	-0.24	0.45	0.1	0.88	0.1	0.26	-0.08	0.96	0.24	0.41	0.92	0.4	-0.02	0.47		1.0	-0.11
Net Working Capital	0.85	0.9	-0.16	-0.24	0.46	0.1	0.88	0.1	0.27	-0.07	0.97	0.24	0.41	0.92	0.4	-0.02	0.47	1.0		-0.1
Capital Stock	0.27	-0.31	0.83	-0.84	0.66	0.86	0.2	0.04	-0.2	0.27	0.03	0.85	0.61	-0.22	0.77	0.16	0.62	-0.11	-0.1

Click cells to compare fundamentals

Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.

Competition

Predict Heron Therapeuti

Heron Return On Tangible Assets

Return On Tangible Assets

(0.52)

At this time, Heron Therapeuti's Return On Tangible Assets are fairly stable compared to the past year.

According to the company disclosure, Heron Therapeuti has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Heron Five Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heron Therapeuti's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heron Therapeuti could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics of similar companies.

Heron Therapeuti is currently under evaluation in five year return category among its peers.

Heron Fundamentals

	Return On Equity	-24.09
	Return On Asset	-0.0231
	Profit Margin	(0.20) %
	Operating Margin	(0.14) %
	Current Valuation	270.1 M
	Shares Outstanding	152.1 M
	Shares Owned By Insiders	0.71 %
	Shares Owned By Institutions	81.56 %
	Number Of Shares Shorted	28.81 M
	Price To Earning	(5.15) X
	Price To Book	12.60 X
	Price To Sales	1.18 X
	Revenue	127.04 M
	Gross Profit	(50.51 M)
	EBITDA	(103.79 M)
	Net Income	(110.56 M)
	Cash And Equivalents	83.54 M
	Cash Per Share	0.81 X
	Total Debt	179.63 M
	Debt To Equity	6.64 %
	Current Ratio	1.77 X
	Book Value Per Share	(0.26) X
	Cash Flow From Operations	(58.79 M)
	Short Ratio	20.19 X
	Earnings Per Share	(0.16) X
	Price To Earnings To Growth	(0.18) X
	Target Price	6.0
	Number Of Employees	126
	Beta	1.81
	Market Capitalization	162.74 M
	Total Asset	222.51 M
	Retained Earnings	(1.91 B)
	Working Capital	109.09 M
	Current Asset	134.75 M
	Current Liabilities	19.73 M
	Net Asset	222.51 M

About Heron Therapeuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC